Sign up for our daily briefing

Make your busy days simpler with Axios AM/PM. Catch up on what's new and why it matters in just 5 minutes.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Stay on top of the latest market trends

Subscribe to Axios Markets for the latest market trends and economic insights. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Sports news worthy of your time

Binge on the stats and stories that drive the sports world with Axios Sports. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Tech news worthy of your time

Get our smart take on technology from the Valley and D.C. with Axios Login. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Get the inside stories

Get an insider's guide to the new White House with Axios Sneak Peek. Sign up for free.

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Catch up on coronavirus stories and special reports, curated by Mike Allen everyday

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Denver news?

Get a daily digest of the most important stories affecting your hometown with Axios Denver

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Des Moines news?

Get a daily digest of the most important stories affecting your hometown with Axios Des Moines

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Twin Cities news?

Get a daily digest of the most important stories affecting your hometown with Axios Twin Cities

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Tampa Bay news?

Get a daily digest of the most important stories affecting your hometown with Axios Tampa Bay

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Want a daily digest of the top Charlotte news?

Get a daily digest of the most important stories affecting your hometown with Axios Charlotte

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

Please enter a valid email.

Please enter a valid email.

Subscription failed
Thank you for subscribing!

The United States does not have a plan to distribute a vaccine for the coronavirus "in a fair and equitable manner" when one becomes available, Rick Bright, a former health official ousted from his position last month, told the House Energy and Commerce Committee on Thursday.

Why it matters: Bright, who led the Biomedical Advanced Research and Development Authority, cautioned that because one company cannot produce enough vaccine for the country, supply will be limited.

What he's saying: "We need to have a plan in place now to make sure that we can not only fill that vaccine, make it, distribute it, but administer it in a fair and equitable plan," he said.

  • Bright criticized the federal government's chaotic rollout of the coronavirus therapy drug remdesivir, which has been shown to help patients recover from the coronavirus more quickly than patients who receive no treatment.
  • "We have limited doses, and we haven't scaled-up production. And we don't have a plan on how to fairly and equitably distribute [remdesivir]."

The big picture: Bright said a vaccine may become available by "this fall, winter, or maybe even next spring." But he cautioned that the 12 to 18 month timeline that has been touted by some in the Trump administration is an "aggressive schedule."

Go deeper: The race to make vaccines faster

Go deeper

Biden says he would issue nationwide stay-at-home order in face of COVID-flu nightmare

Joe Biden accepts the Democratic Party nomination on Aug. 20. Photo: Olivier Douliery/AFP via Getty Images

Former Vice President Joe Biden told ABC News on Friday that, if elected, he would issue a nationwide stay-at-home order at the recommendation of scientists if coronavirus infections surged in January alongside the flu season.

Why it matters: The country's coronavirus crisis could worsen this winter if hospitals are overwhelmed with patients requiring care from COVID-19 at the same time as the flu. The severity of the influenza season also depends on how many Americans get flu shots.

Aug 21, 2020 - Health

Trump administration blocks FDA from regulating lab-developed tests

Photo: Pier Marco Tacca/Getty Images

The Department of Health and Human Services this week blocked the Food and Drug Administration's ability to regulate lab-developed tests, including for the coronavirus, that have been produced by hundreds of hospitals.

What they're saying: The change prohibits the FDA from overseeing such tests before they're marketed without a detailed rule-making process. HHS said it is taking the action as part of broader Trump administration review of "duplicative actions and unnecessary policies."

Updated Mar 2, 2021 - Politics & Policy

Coronavirus dashboard

Illustration: Aïda Amer/Axios

  1. Health: CDC director warns "now is not the time" to lift COVID restrictions — Exclusive: Teenagers' mental health claims doubled last spring.
  2. Axios-Ipsos poll: Americans' hopes rise after a year of COVID
  3. Vaccine: J&J CEO "absolutely" confident in vaccine distribution goals — Vaccine hesitancy is shrinking.
  4. World: China and Russia vaccinate the world, for now.
  5. Energy: Global carbon emissions rebound to pre-COVID levels.
  6. Local: Florida gets more good vaccine newsMinnesota's hunger problem grows amid pandemic — Denver's fitness industry eyes a pandemic recovery.